As illustrated in Fig. 1a, the severe/critical COVID-19 patients had a significantly higher proportion of positive anti-IFN-γ autoAbs (7/39, 18.0%) than non-severe patients (3.4%, p <0.01) or HC subjects (0.0%, p <0.05). Here, IFNG is linked to COVID-19.